MTP 219
Alternative Names: [Ga-68]MTP-220; MTP-219Latest Information Update: 15 May 2024
At a glance
- Originator Molecular Theranostics
- Class Imaging agents; Peptide diagnostics; Radioisotopes; Radiopharmaceutical diagnostics
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 29 Apr 2024 Early research in Solid tumours (Diagnosis) in USA (Parenteral) (Molecular Theranostics pipeline, April 2024)